EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Update on siRNA Therapeutics

Oluwakemi Ebenezer iD, Abel Kolawole Oyebamiji iD, John Oludele Olanlokun iD, Jack A Tuszynski iD, Gane Ka-Shu Wong iD

International Journal of Molecular Sciences · 08.04.2025 · 26 (8) · 3456

DOI: 10.3390/ijms26083456 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.04.2025. Verfasst von Oluwakemi Ebenezer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, University of Alberta, Edmonton, AB T6G 2E1, Canada. Hauptthemen laut MEDLINE: RNA, Small Interfering, Genetic Therapy. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small interfering RNA (siRNA) has been deemed a promising therapeutic method for treating diverse diseases. siRNA-based therapeutics provide a distinct mechanism of action by selectively targeting and silencing disease-causing genes at the post-transcriptional level. This paper provides an overview of the present state of siRNA-based therapeutics, highlighting their potential in different therapeutic areas. The first section of this review introduces the basic principles of siRNA technology, including its mechanism of action and delivery methods. Subsequently, we discuss the impediments associated with siRNA delivery and manufacturing development and the strategies for overcoming these obstacles. The clinical advancement of siRNA therapeutics in various disease areas, including cancer, genetic disorders, viral infections, and inflammatory diseases, is summarized. Lastly, we summarize the successes, failures, and lessons learned from the development of siRNAs. With advancements in delivery systems and improvements in target selection, the field of medicine can be revolutionized, and siRNA therapeutics can offer new treatment options for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingGenetic TherapyHumansAnimalsNeoplasmsRNA InterferenceGene Transfer TechniquesDrug Delivery SystemsGene SilencingVirus Diseases

Stichwörter der Autor:innen

clinical trialdiseasesgene therapysiRNAsiRNA therapeuticstri-GalNAc conjugates

Substanzen

RNA, Small Interfering

Autor:innen und Institutionen

  • Department of Physics, University of Alberta, Edmonton, AB T6G 2E1, Canada.
  • Department of Industrial Chemistry, University of Ilesa, Ilesa PMB 5089, Nigeria.
  • Laboratories for Biomembrane Research and Biotechnology, Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan 200005, Nigeria.
  • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
  • Department of Mechanical and Aerospace Engineering (DIMEAS), Politecnico di Torino, 10129 Turin, Italy.
  • Department of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland.

ORCID-Profile: Oluwakemi Ebenezer, Abel Kolawole Oyebamiji, John Oludele Olanlokun, Jack A Tuszynski, Gane Ka-Shu Wong

Zitieren

APA

Ebenezer, O., Oyebamiji, A. K., Olanlokun, J. O., Tuszynski, J. A., & Wong, G. K. (2025). Recent Update on siRNA Therapeutics. International Journal of Molecular Sciences, 26(8), 3456. https://doi.org/10.3390/ijms26083456

Vancouver

Ebenezer O, Oyebamiji AK, Olanlokun JO, Tuszynski JA, Wong GK. Recent Update on siRNA Therapeutics. International Journal of Molecular Sciences. 2025;26(8):3456. doi:10.3390/ijms26083456

BibTeX
@article{Ebenezer2025,
  author = {Ebenezer, Oluwakemi and Oyebamiji, Abel Kolawole and Olanlokun, John Oludele and Tuszynski, Jack A and Wong, Gane Ka-Shu},
  title = {Recent Update on siRNA Therapeutics},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3456},
  doi = {10.3390/ijms26083456}
}
Kostenlos starten →